Limitations, agreements, and source contact

UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide · Source last updated 2017-11-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

Early termination led to small numbers of subjects to be analyzed. Less than 10% of the target accrual were enrolled before termination of study.

point Of Contact

email

PettyNathanM@uams.edu

organization

University of Arkansas for Medical Sciences, Myeloma Institute

phone

501-526-6990

phone Ext

2461

title

Nathan M. Petty

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice